Login / Signup

Malignant salivary gland tumours in families with breast cancer susceptibility.

Carla B RipamontiPaolo BossiSiranoush ManoukianLaura Deborah LocatiMara ColomboMaria L CarcangiuAndrea VingianiLisa F LicitraPaolo Radice
Published in: Virchows Archiv : an international journal of pathology (2021)
Salivary gland cancers (SGCs) are rare malignancies with highly heterogeneous histological features. Patients affected with SGCs are at increased risk of secondary malignancies, including breast cancer (BC). Previous studies enlightened a possible link between SGCs and hereditary predisposition to BC. Here, we searched for SGC-affected patients in 1796 high-risk BC families recruited at the Genetic Unit of the Istituto Nazionale dei Tumori of Milan, 516 of which carried pathogenic variants in BRCA1 and/or BRCA2, the main genetic risk factors for BC. We detected five families with an individual affected with SGC, including two male patients, one carrying a constitutional mutation in BRCA1 and the other in BRCA2. Loss of heterozygosity of BRCA wild-type alleles was assessed in the patients' tumour DNA. We conclude that our observations support the hypothesis that genetic factors associated with BC susceptibility might play a role also in at least a subset of SGCs.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • genome wide
  • gene expression
  • copy number
  • dna methylation
  • breast cancer risk
  • young adults
  • circulating tumor